Business
Telemedicine Stocks Sector Snapshot - COVID-19 and the Accelerating Rise of Telemedicine and Innovation in Healthcare
Point Roberts, Washington and Delta, British Columbia--(Newsfile Corp. - September 25, 2020) -...
About this update from Getchell Gold Corp.
[{"type":"text","content":"Telemedicine Stocks Sector Snapshot - COVID-19 and the Accelerating Rise of Telemedicine and Innovation in HealthcarePoint Roberts, Washington and Delta, British Columbia--(Newsfile Corp. - September 25, 2020) -  Investorideas.com, a global news source and leading retail investor and trader resource issues a sector snapshot looking at the growing telemedicine market and participating public companies rising to meet the needs of innovation in healthcare, including GBT Technologies Inc. (OTC Pink: GTCH). Telemedicine - the practice of providing or distributing healthcare-related services and information remotely, through digital and telecommunications technology means - is one of the fortunate industries to have risen in significance during the COVID-19 pandemic. The reasons for this are perhaps not difficult to guess. The prominence of social distancing guidelines and more particularly, the widespread policy (or advocacy for) quarantining has made traditional visits to clinics and hospitals more difficult. And in the months since the COVID-19 outbreak, this has been exacerbated at times by the delaying and postponing of non-emergent care. Naturally, this has led to the benefits of telemedicine, such as the ability to long-distant diagnose, inform, and monitor patients, making it even more relevant during this pandemic.This is not to give the impression however, that telemedicine would not have become a consequential market regardless of a crisis like COVID-19. According to a report published before COVID-19, from Fortune Business Insights, the global market for telemedicine was valued at USD $34.28 billion in 2018, and is projected to reach USD $185.66 billion by 2026, making for a compound annual growth rate (CAGR) of 23.5 percent in the forecast period (2019-2026). But similar to other markets, like digital retail, telemedicine was already gaining traction and was well-positioned to meet the increasing demand brought on by the virus.Like many emerging industries, the telemedicine space is seeing the surfacing of a panoply of different solutions. This is exemplified by qTerm, an AI-powered human vitals device from GBT Technologies Inc. (OTC Pink: GTCH) and its Joint Venture GBT Tokenize Corp. According to a recent press release, the qTerm device \"is targeted to measure body temperature, blood pressure, and heart rate - all...